• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复溶后纤维蛋白原浓缩物的潜在延长时间。

Potential for prolongation of fibrinogen concentrates post-reconstitution.

机构信息

Department of Pathology and Laboratory Medicine, University of British Columbia, Rm. G227-2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, 2775 Laurel Street, Vancouver, BC V5Z 1M9, Canada.

Department of Pathology and Laboratory Medicine, University of British Columbia, Rm. G227-2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, 2775 Laurel Street, Vancouver, BC V5Z 1M9, Canada.

出版信息

Transfus Apher Sci. 2023 Jun;62(3):103657. doi: 10.1016/j.transci.2023.103657. Epub 2023 Feb 14.

DOI:10.1016/j.transci.2023.103657
PMID:36804189
Abstract

BACKGROUND AND OBJECTIVES

Reconstituted fibrinogen concentrate is considered stable for 8-24 h based on product monographs. Given the long half-life of fibrinogen in vivo (3-4 days), we hypothesized that reconstituted sterile fibrinogen protein would remain stable longer than 8-24 h. Extending the expiry date for reconstituted fibrinogen concentrate could decrease wastage and facilitate reconstitution in advance to minimize turnaround times. We performed a pilot study to define the stability of reconstituted fibrinogen concentrates over time.

MATERIALS AND METHODS

Reconstituted Fibryga® (Octapharma AG) from 64 vials was stored in the temperature-controlled refrigerator (4 °C) for up to 7 days with functional fibrinogen concentration measured serially using the automated Clauss method. The samples were frozen, then thawed and diluted with pooled normal plasma in order for them to be batch tested.

RESULTS

Reconstituted fibrinogen samples stored in the refrigerator showed no significant reduction in functional fibrinogen concentration for the entire 7-day study period (p = 0.63). Duration of initial freezing had no detrimental effect on functional fibrinogen levels (p = 0.23).

CONCLUSION

Fibryga® can be stored at 2-8 °C post-reconstitution for up to one week with no loss in functional fibrinogen activity based on Clauss fibrinogen assay. Further studies with other fibrinogen concentrate formulations and clinical in vivo studies may be warranted.

摘要

背景与目的

根据产品说明书,复溶纤维蛋白原浓缩物在 8-24 小时内被认为是稳定的。鉴于纤维蛋白原在体内的半衰期较长(3-4 天),我们假设复溶的无菌纤维蛋白原蛋白的稳定性将超过 8-24 小时。延长复溶纤维蛋白原浓缩物的有效期可以减少浪费,并提前进行复溶,以最大限度地减少周转时间。我们进行了一项试点研究,以确定复溶纤维蛋白原浓缩物随时间的稳定性。

材料与方法

将 64 瓶来自 Octapharma AG 的 Fibryga®复溶后储存在控温冰箱(4°C)中,最长可达 7 天,使用自动化 Clauss 法连续测量功能性纤维蛋白原浓度。将样本冷冻,然后解冻并与混合正常血浆稀释,以便进行批量测试。

结果

在整个 7 天的研究期间,储存在冰箱中的复溶纤维蛋白原样本的功能性纤维蛋白原浓度没有显著降低(p=0.63)。初始冷冻时间的长短对功能性纤维蛋白原水平没有不利影响(p=0.23)。

结论

根据 Clauss 纤维蛋白原测定法,Fibryga®在复溶后可在 2-8°C 下储存长达一周,而功能性纤维蛋白原活性无损失。可能需要对其他纤维蛋白原浓缩物制剂进行进一步研究,并进行临床体内研究。

相似文献

1
Potential for prolongation of fibrinogen concentrates post-reconstitution.复溶后纤维蛋白原浓缩物的潜在延长时间。
Transfus Apher Sci. 2023 Jun;62(3):103657. doi: 10.1016/j.transci.2023.103657. Epub 2023 Feb 14.
2
Stability of Reconstituted Fibrinogen Concentrate in Hemostatic Function and Concentration.复溶纤维蛋白原浓缩物的止血功能和浓度稳定性。
Mil Med. 2021 Feb 26;186(3-4):286-292. doi: 10.1093/milmed/usaa409.
3
The activity of labile coagulation factors and fibrinogen in thawed plasma during a 5 day storage period in the hospital blood bank refrigerator.在医院血库冰箱中储存 5 天期间,解冻血浆中不稳定凝血因子和纤维蛋白原的活性。
Transfus Med. 2021 Dec;31(6):494-498. doi: 10.1111/tme.12823. Epub 2021 Oct 3.
4
Stability of Fibrinogen Concentrate in Human Blood Samples: An In Vitro Study.人血样本中纤维蛋白原浓缩物的稳定性:一项体外研究。
Mil Med. 2018 Mar 1;183(suppl_1):183-188. doi: 10.1093/milmed/usx176.
5
Comparison of the efficacy of two human fibrinogen concentrates to treat dilutional coagulopathy in vitro.两种人纤维蛋白原浓缩物治疗体外稀释性凝血病疗效的比较。
Scand J Clin Lab Invest. 2018 May;78(3):230-235. doi: 10.1080/00365513.2018.1437645. Epub 2018 Feb 15.
6
In vitro efficacy of RiaSTAP after rapid reconstitution.快速复溶后 RiaSTAP 的体外疗效。
J Surg Res. 2014 Aug;190(2):655-61. doi: 10.1016/j.jss.2014.01.055. Epub 2014 Feb 6.
7
Comparison of fresh frozen plasma vs. coagulation factor concentrates for reconstitution of blood: An in vitro study.新鲜冷冻血浆与凝血因子浓缩物用于血液复配的比较:一项体外研究。
Eur J Anaesthesiol. 2020 Oct;37(10):879-888. doi: 10.1097/EJA.0000000000001202.
8
Stability of ex vivo coagulation factor activity in never-frozen and thawed refrigerated canine plasma stored for 42 days.从未冷冻和解冻的冷藏犬血浆中储存 42 天对体外凝血因子活性的稳定性。
J Vet Emerg Crit Care (San Antonio). 2022 Mar;32(2):189-195. doi: 10.1111/vec.13152. Epub 2021 Nov 12.
9
Hemostatic characteristics of thawed, pooled cryoprecipitate stored for 35 days at refrigerated and room temperatures.在冷藏和室温下储存35天的解冻混合冷沉淀的止血特性。
Transfusion. 2019 Apr;59(S2):1560-1567. doi: 10.1111/trf.15180.
10
Biochemical characterization, stability, and pathogen safety of a new fibrinogen concentrate (fibryga).新型纤维蛋白原浓缩物(Fibryga)的生化特性、稳定性及病原体安全性
Biologicals. 2018 Mar;52:72-77. doi: 10.1016/j.biologicals.2017.12.003. Epub 2018 Jan 12.